24 results
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
Accounting Oversight Board (United States) (the “PCAOB”).
(t)The Company maintains a system of internal control over financial reporting (as such term
PRE 14A
VKTX
Viking Therapeutics Inc
17 Apr 23
Preliminary proxy
5:04pm
. Mancini has over 30 years of experience in the pharmaceutical and biotechnology industry focusing on the management and oversight of clinical trials … of six members. The primary responsibilities of our Board are to provide oversight, strategic guidance, counseling and direction to our management
8-K
EX-1.1
j69ip6qch4xmd
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
8-K
xpteq
6 Jan 21
Departure of Directors or Certain Officers
4:15pm
8-K
EX-1.1
zv269aokak05mzx56u
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
8-K
EX-1.1
xr0t56dm151107 c3dz7
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm